Credit Suisse’s Hanwha Q CELLS Co., Ltd. HQCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-25,315
Closed -$206K 4210
2016
Q4
$206K Buy
+25,315
New +$249K ﹤0.01% 3802
2015
Q2
Sell
-1,973
Closed -$40K 4707
2015
Q1
$40K Buy
1,973
+108
+6% +$1.29K ﹤0.01% 4293
2014
Q4
$21K Buy
1,865
+612
+49% +$10.8K ﹤0.01% 4548
2014
Q3
$30K Sell
1,253
-987
-44% -$22.7K ﹤0.01% 4376
2014
Q2
$62K Buy
2,240
+725
+48% +$18.7K ﹤0.01% 4583
2014
Q1
$43K Sell
1,515
-8,936
-86% -$275K ﹤0.01% 4585
2013
Q4
$290K Buy
+10,451
New +$420K ﹤0.01% 4101
2013
Q3
Sell
-4,193
Closed -$87K 4447
2013
Q2
$87K Buy
+4,193
New +$55.5K ﹤0.01% 4044

Other funds holding HQCL

Credit Suisse's HQCL Position: Q1 2017 in Review

Credit Suisse sold out of Hanwha Q CELLS Co., Ltd. (HQCL) in Q1 2017, closing a stake of 25,315 shares — an estimated $206K sold.

Credit Suisse first reported a position in HQCL in Q2 2013 and held it in 8 quarters. The position peaked at $290K in Q4 2013. 13 funds tracked by Wall St. Rank hold HQCL as of Q1 2017.

  • Credit Suisse reported no remaining Hanwha Q CELLS Co., Ltd. position as of Q1 2017 after selling out during the quarter.
  • Credit Suisse sold 25,315 Hanwha Q CELLS Co., Ltd. shares in Q1 2017, an estimated $206K.
  • Credit Suisse first reported a position in Hanwha Q CELLS Co., Ltd. in Q2 2013 and held it in 8 quarters.
  • Credit Suisse's Hanwha Q CELLS Co., Ltd. position peaked at $290K in Q4 2013.
  • 13 funds tracked by Wall St. Rank held Hanwha Q CELLS Co., Ltd. as of Q1 2017.

Based on Credit Suisse's 13F filing for Q1 2017, filed 15 May 2017.